about
Epileptic encephalopathies: new genes and new pathwaysGenetic basis of pediatric epilepsy syndromes.Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.The Current Status of the Ketogenic Diet in Psychiatry.Functional neuroimaging in epileptic encephalopathies.Therapeutic approach to epileptic encephalopathies.Clinical management of epileptic encephalopathies of childhood and infancy.Childhood Electroclinical Syndromes: a diagnostic and therapeutic algorithm.Epileptic encephalopathies: Optimizing seizure control and developmental outcome.Current Treatment Options for Early-Onset Pediatric Epileptic Encephalopathies.Modified Atkins diet is an effective treatment for children with Doose syndrome.Cannabidiol as potential treatment in refractory pediatric epilepsy.The Clinical Spectrum of Benign Epilepsy with Centro-Temporal Spikes: a Challenge in Categorization and Predictability.Dravet in the dish: mechanisms of hyperexcitability.The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study.Adrenocorticotropic hormone protects learning and memory function in epileptic Kcna1-null mice.Entropy measures to study and model long term simultaneous evolution of children in Doose and Lennox-Gastaut syndromes.Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From GermanyMechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones
P2860
Q27027982-0DD298BF-00D1-4A1F-B1A5-9F4FB15962E0Q33723915-7AB542BE-AAB3-4968-A534-367C9BC88E78Q34146329-8F78B017-C806-4ED4-A26F-6AB94C494B02Q37710385-F4535314-54D8-46FC-9A1A-4E7A8AB866EDQ38191246-D062B983-961E-4C57-BA7D-93D7761DF78DQ38191250-BF8C1B1E-39C9-44EB-AB89-9D0458803DCBQ38213837-F2767EE1-6992-458C-8A3B-C151D9F3FC3DQ38237593-AEFCA6CF-868F-463E-92E2-39CFE4A747CDQ38570587-19BF0F28-485B-4B42-B774-5E3005B32394Q38946719-BD223033-FB79-4EC2-8C0F-E8FCF5603EFCQ38946949-F99193A8-F8B1-4F19-BF2E-D02E75122B01Q40322142-3B5FACDB-14A9-4DB7-8558-C7E9A98445E9Q41217989-468E6705-ECAD-4BA0-8306-D483E7B311D6Q41830959-19023466-FC87-45B8-BD96-2D5D92C5BF50Q42317941-6409720D-6641-4780-A64E-E7C35A978198Q47758860-8E6C96DB-93C0-41D4-8851-719FCEB9A44DQ48655595-06233D30-0E5D-4D92-AA62-E9579DC02A52Q57926644-50817AF9-A95D-490D-B304-7B6881617F6AQ59126308-95BCF6CE-D434-4200-A575-1C16E877E449
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Treatment of epileptic encephalopathies
@ast
Treatment of epileptic encephalopathies
@en
Treatment of epileptic encephalopathies
@nl
type
label
Treatment of epileptic encephalopathies
@ast
Treatment of epileptic encephalopathies
@en
Treatment of epileptic encephalopathies
@nl
prefLabel
Treatment of epileptic encephalopathies
@ast
Treatment of epileptic encephalopathies
@en
Treatment of epileptic encephalopathies
@nl
P2860
P1433
P1476
Treatment of epileptic encephalopathies
@en
P2093
J Helen Cross
P2860
P2888
P304
P356
10.1007/S40263-013-0041-6
P407
P50
P577
2013-03-01T00:00:00Z